| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 0 | 0 | 204.860 | 1.443.945 | 3.153.183 | 6.397.665 |
| Total Income - EUR | - | - | - | 0 | 0 | 0 | 204.925 | 1.452.339 | 3.163.969 | 6.431.412 |
| Total Expenses - EUR | - | - | - | 556 | 0 | 77 | 155.713 | 1.025.625 | 1.760.964 | 4.457.887 |
| Gross Profit/Loss - EUR | - | - | - | -556 | 0 | -77 | 49.212 | 426.714 | 1.403.005 | 1.973.526 |
| Net Profit/Loss - EUR | - | - | - | -556 | 0 | -77 | 44.675 | 373.925 | 1.221.953 | 1.664.052 |
| Employees | - | - | - | 0 | 0 | 0 | 1 | 2 | 2 | 3 |
Check the financial reports for the company - Neobral S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 58.759 | 75.214 | 240.073 | 293.205 |
| Current Assets | - | - | - | 36 | 35 | -1 | 154.456 | 697.397 | 2.604.095 | 2.552.468 |
| Inventories | - | - | - | 18 | 17 | 0 | 62.943 | 290.731 | 1.009.819 | 672.295 |
| Receivables | - | - | - | 0 | 0 | 0 | 29.057 | 306.866 | 928.360 | 1.778.691 |
| Cash | - | - | - | 18 | 18 | -1 | 62.456 | 99.800 | 665.917 | 101.481 |
| Shareholders Funds | - | - | - | -1.020 | -1.000 | -1.017 | 43.680 | 417.741 | 1.551.544 | 1.688.513 |
| Social Capital | - | - | - | 43 | 42 | 83 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | 1.056 | 1.035 | 1.016 | 169.535 | 354.871 | 1.292.625 | 1.157.161 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4614 - 4614" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Neobral S.r.l.